0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer characterized by metabolic reprogramming. Glutamine metabolism is pivotal in metabolic reprogramming, contributing to the significant heterogeneity observed in ccRCC. Consequently, developing prognostic markers associated with glutamine metabolism could enhance personalized treatment strategies for ccRCC patients. This study obtained RNA sequencing and clinical data from 763 ccRCC cases sourced from multiple databases. Consensus clustering of 74 glutamine metabolism related genes (GMRGs)- profiles stratified the patients into three clusters, each of which exhibited distinct prognosis, tumor microenvironment, and biological characteristics. Then, six genes (SMTNL2, MIOX, TMEM27, SLC16A12, HRH2, and SAA1) were identified by machine-learning algorithms to develop a predictive signature related to glutamine metabolism, termed as GMRScore. The GMRScore showed significant differences in clinical prognosis, expression profile of immune checkpoints, abundance of immune cells, and immunotherapy response of ccRCC patients. Besides, the nomogram incorporating the GMRScore and clinical features showed strong predictive performance in prognosis of ccRCC patients. ALDH18A1, one of the GRMGs, exhibited elevated expression level in ccRCC and was related to markedly poorer prognosis in the integrated cohort, validated by proteomic profiling of 232 ccRCC samples from Fudan University Shanghai Cancer Center (FUSCC). Conducting western blotting, CCK-8, transwell, and flow cytometry assays, we found the knockdown of ALDH18A1 in ccRCC significantly promoted apoptosis and inhibited proliferation, invasion, and epithelial-mesenchymal transition (EMT) in two human ccRCC cell lines (786-O and 769-P). In conclusion, we developed a glutamine metabolism-related prognostic signature in ccRCC, which is tightly linked to the tumor immune microenvironment and immunotherapy response, potentially facilitating precision therapy for ccRCC patients. Additionally, this study revealed the key role of ALDH18A1 in promoting ccRCC progression for the first time.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s10238-024-01390-4.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: not found

          clusterProfiler: an R package for comparing biological themes among gene clusters.

          Increasing quantitative data generated from transcriptomics and proteomics require integrative strategies for analysis. Here, we present an R package, clusterProfiler that automates the process of biological-term classification and the enrichment analysis of gene clusters. The analysis module and visualization module were combined into a reusable workflow. Currently, clusterProfiler supports three species, including humans, mice, and yeast. Methods provided in this package can be easily extended to other species and ontologies. The clusterProfiler package is released under Artistic-2.0 License within Bioconductor project. The source code and vignette are freely available at http://bioconductor.org/packages/release/bioc/html/clusterProfiler.html.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            GSVA: gene set variation analysis for microarray and RNA-Seq data

            Background Gene set enrichment (GSE) analysis is a popular framework for condensing information from gene expression profiles into a pathway or signature summary. The strengths of this approach over single gene analysis include noise and dimension reduction, as well as greater biological interpretability. As molecular profiling experiments move beyond simple case-control studies, robust and flexible GSE methodologies are needed that can model pathway activity within highly heterogeneous data sets. Results To address this challenge, we introduce Gene Set Variation Analysis (GSVA), a GSE method that estimates variation of pathway activity over a sample population in an unsupervised manner. We demonstrate the robustness of GSVA in a comparison with current state of the art sample-wise enrichment methods. Further, we provide examples of its utility in differential pathway activity and survival analysis. Lastly, we show how GSVA works analogously with data from both microarray and RNA-seq experiments. Conclusions GSVA provides increased power to detect subtle pathway activity changes over a sample population in comparison to corresponding methods. While GSE methods are generally regarded as end points of a bioinformatic analysis, GSVA constitutes a starting point to build pathway-centric models of biology. Moreover, GSVA contributes to the current need of GSE methods for RNA-seq data. GSVA is an open source software package for R which forms part of the Bioconductor project and can be downloaded at http://www.bioconductor.org.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

              Summary: Unsupervised class discovery is a highly useful technique in cancer research, where intrinsic groups sharing biological characteristics may exist but are unknown. The consensus clustering (CC) method provides quantitative and visual stability evidence for estimating the number of unsupervised classes in a dataset. ConsensusClusterPlus implements the CC method in R and extends it with new functionality and visualizations including item tracking, item-consensus and cluster-consensus plots. These new features provide users with detailed information that enable more specific decisions in unsupervised class discovery. Availability: ConsensusClusterPlus is open source software, written in R, under GPL-2, and available through the Bioconductor project (http://www.bioconductor.org/). Contact: mwilkers@med.unc.edu Supplementary Information: Supplementary data are available at Bioinformatics online.
                Bookmark

                Author and article information

                Contributors
                xwhao0407@163.com
                larrybird007@163.com
                dwyelie@163.com
                zhanghl918@163.com
                Journal
                Clin Exp Med
                Clin Exp Med
                Clinical and Experimental Medicine
                Springer International Publishing (Cham )
                1591-8890
                1591-9528
                6 July 2024
                6 July 2024
                2024
                : 24
                : 1
                : 152
                Affiliations
                [1 ]Department of Urology, Fudan University Shanghai Cancer Center, ( https://ror.org/00my25942) Shanghai, 200032 People’s Republic of China
                [2 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, Department of Oncology, Shanghai Medical College, , Fudan University, ; Shanghai, 200032 People’s Republic of China
                [3 ]Shanghai Genitourinary Cancer Institute, Shanghai, 200032 People’s Republic of China
                [4 ]Department of Urology, The Affiliated Taian City Central Hospital of Qingdao University, ( https://ror.org/04vsn7g65) Taian, 271000 People’s Republic of China
                [5 ]Affiliated Hospital of Youjiang Medical University for Nationalities, ( https://ror.org/0358v9d31) Baise, 533000 People’s Republic of China
                Article
                1390
                10.1007/s10238-024-01390-4
                11227463
                38970690
                47445f31-d050-46fb-ad06-99ce0cd9e8c5
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 20 April 2024
                : 5 June 2024
                Funding
                Funded by: "Fuqing Scholar" Student Scientific Research Program of Shanghai Medical College, Fudan University
                Award ID: No. FQXZ202304A
                Award Recipient :
                Funded by: Shanghai Anticancer Association EYAS PROJECT
                Award ID: SACA-CY23A02 and SACA-CY23C04
                Award ID: SACA-CY23A02 and SACA-CY23C04
                Award Recipient :
                Funded by: Shanghai Municipal Health Bureau Project
                Award ID: No. 2020CXJQ03
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100018904, Beijing Xisike Clinical Oncology Research Foundation;
                Award ID: No. Y-HR2020MS-0948
                Award Recipient :
                Funded by: China Anti-Cancer Association- Hengrui PARP Nicotinamide Cancer Research Fund
                Award ID: CETSDHRCORP252-4-021
                Award Recipient :
                Categories
                Research
                Custom metadata
                © Springer Nature Switzerland AG 2024

                Medicine
                clear cell renal cell carcinoma,glutamine metabolism,tumor microenvironment,prognosis,immunotherapy response,aldh18a1

                Comments

                Comment on this article